Moderna Analyst Ratings
BenzingaApr 11 07:36 ET
Moderna Analyst Ratings
BenzingaApr 9 12:09 ET
Moderna Analyst Ratings
BenzingaMar 28 11:56 ET
Moderna Analyst Ratings
BenzingaMar 28 05:45 ET
Moderna Analyst Ratings
BenzingaFeb 26 06:45 ET
Moderna Analyst Ratings
BenzingaFeb 23 09:51 ET
Critical Insights From Moderna Analyst Ratings: What You Need To Know
BenzingaJan 12 12:00 ET
RBC Capital Reiterates Outperform on Moderna, Maintains $125 Price Target
BenzingaJan 12 11:28 ET
Moderna Analyst Ratings
BenzingaJan 12 11:27 ET
Oppenheimer Lifts Moderna Rating on Key 2024/2025 Catalysts
InvestingJan 2 08:22 ET
Oppenheimer Upgrades Moderna to Outperform, Announces $142 Price Target
BenzingaJan 2 07:43 ET
Moderna Analyst Ratings
BenzingaJan 2 07:42 ET
Morgan Stanley Cuts Price Target on Moderna to $92 From $115, Keeps Equalweight Rating
MT NewswiresDec 12, 2023 08:05 ET
Moderna Analyst Ratings
BenzingaDec 1, 2023 14:40 ET
JPMorgan Adjusts Moderna Price Target to $90 From $93, Maintains Neutral Rating
MT NewswiresDec 1, 2023 10:13 ET
Canaccord Genuity Initiates Coverage On Moderna With Hold Rating, Announces Price Target of $82
BenzingaNov 29, 2023 05:16 ET
Moderna Analyst Ratings
BenzingaNov 29, 2023 05:15 ET
UBS Lowers Moderna's Price Target to $143 From $178, Keeps Buy Rating
MT NewswiresNov 6, 2023 13:13 ET
Moderna Analyst Ratings
BenzingaNov 3, 2023 15:11 ET
Goldman Sachs Maintains Buy on Moderna, Lowers Price Target to $231
BenzingaNov 3, 2023 10:51 ET
No Data
No Data